Do you have pterygium, also known as Surfer’s Eye?
Pterygium is a thin growth of clear tissue with redness, due to small blood vessels that start at the corner of the eye and grow towards the centre of the cornea.
We are currently investigating a potential new medication to treat the redness associated with Surfer’s Eye. This new treatment involves the self-administration of eye drops, 3 times per day for 28 days.
Participants will be required to attend a screening visit to determine eligibility for the trial, followed by 5 additional clinic visits over a 3 month period.
We are currently recruiting study participants who:
- Are 18 years of age or older
- Have a pterygium in one or both eyes, that is also associated with eye redness.
- Are willing to attend 6 clinic visits over 3 months
To see if you are eligible complete the questionnaire below or call the Clinical Trials Centre on 07 5456 3797.
Full title: A Multicenter, Prospective, Randomized, Double- Masked, Phase 2 Study Evaluating the Safety, Tolerability, and Efficacy of Topical AG-86893 in Patients with Pterygium
Ethics approval – Bellberry Human Research Ethics Committee
If you experience difficulty completing the survey please email firstname.lastname@example.org